No abstract available
Keywords:
Fasciola hepatica; Porto; Portugal; fascioliasis; infection.
PubMed Disclaimer
Comment on
-
Human liver flukes.
Harrington D, Lamberton PHL, McGregor A.
Harrington D, et al.
Lancet Gastroenterol Hepatol. 2017 Sep;2(9):680-689. doi: 10.1016/S2468-1253(17)30111-5.
Lancet Gastroenterol Hepatol. 2017.
PMID: 28786389
Review.
References
-
-
Harrington D, Lamberton P, McGregor A. Human liver flukes. Lancet Gastroenterol Hepatol (2017) 2:680–9.10.1016/S2468-1253(17)30111-5
-
DOI
-
PubMed
-
-
Ferreira S, Fernandes R, Alves H, Richter J, Botelho MC. Anti-cancer potential of Fasciola hepatica extracts. Trop Med Int Health (2017) 22:124.10.1111/tmi.12979
-
DOI
-
PubMed
-
-
Dias L, Silva R, Viana H, Palhinhas M, Viana R. Biliary fascioliasis: diagnosis, treatment and follow-up by ERCP. Gastrointest Endosc (1996) 43:6.10.1016/S0016-5107(96)70203-1
-
DOI
-
PubMed
-
-
Mas-Coma S, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ (1999) 77:340–6.
-
PMC
-
PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources